Delta 9 Cannabis Inc (CVE:NINE) Director Acquires C$58,240.00 in Stock

Delta 9 Cannabis Inc (CVE:NINEGet Rating) Director John William (John) Arbuthnot Iv bought 208,000 shares of the firm’s stock in a transaction on Tuesday, February 15th. The shares were purchased at an average cost of C$0.28 per share, with a total value of C$58,240.00. Following the completion of the transaction, the director now owns 17,088,450 shares in the company, valued at C$4,784,766.

NINE stock traded up C$0.03 on Thursday, hitting C$1.03. 68,728 shares of the company’s stock were exchanged, compared to its average volume of 117,300. Delta 9 Cannabis Inc has a 12-month low of C$0.92 and a 12-month high of C$2.35. The firm has a 50 day moving average price of C$1.03 and a two-hundred day moving average price of C$1.03. The company has a debt-to-equity ratio of 33.00, a quick ratio of 2.04 and a current ratio of 4.44. The stock has a market cap of C$89.36 million and a P/E ratio of 19.07.

About Delta 9 Cannabis (Get Rating)

Delta 9 Cannabis Inc operates as an integrated cannabis company. The company, through its subsidiary, Delta 9 Bio-Tech Inc, engages in the production of medical marijuana. It primarily provides cannabis strains, as well as start-up materials and support services, including genetics (plants), grow pods, and consulting services to new and existing licensed producers.

See Also

Insider Buying and Selling by Quarter for Delta 9 Cannabis (CVE:NINE)

Receive News & Ratings for Delta 9 Cannabis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Delta 9 Cannabis and related companies with MarketBeat.com's FREE daily email newsletter.